Research Keyword: diagnostic accuracy

Assessing the Validity and Impact of Remote Digital Image Reading in Fungal Diagnostics

This study tested whether trained mycologists could accurately identify fungal infections from digital images viewed remotely, similar to how radiologists review X-rays. Five experienced laboratory professionals analyzed 474 images of different fungi with accuracy rates between 78-93%. The results suggest that remote digital diagnosis could help hospitals in developing countries where expert mycologists are scarce, enabling faster and more accurate diagnosis of serious fungal infections.

Read More »

Closing the diagnostic gap in medical mycology: The LODDY Test for identification of Lodderomyces elongisporus

Researchers developed a simple and affordable test called the LODDY Test to identify a dangerous yeast called Lodderomyces elongisporus that is often mistaken for a similar but less dangerous yeast. This test uses color changes on a special culture medium to distinguish between different yeast species in just 48 hours without expensive equipment. The test works perfectly in laboratories worldwide and could help doctors in developing countries diagnose and treat serious fungal infections more quickly and accurately.

Read More »

Diagnostic Performance of a PCR-Based Approach for the Diagnosis of Dermatomycosis

This study evaluated a new testing method combining DNA analysis (PCR) with traditional microscopy and culture to diagnose fungal skin, hair, and nail infections. The PCR method detects the infection quickly and accurately, identifying the specific fungus causing the problem within days rather than weeks. The study of over 4,400 samples found that Trichophyton rubrum was the most common cause of fungal infections, and the combined testing approach was 98.5% accurate while reducing unnecessary lab work.

Read More »

Usefulness of Serum as a Non-Invasive Sample for the Detection of Histoplasma capsulatum Infections: Retrospective Comparative Analysis of Different Diagnostic Techniques and Quantification of Host Biomarkers

This study examined whether using blood serum samples is practical for diagnosing histoplasmosis, a serious fungal infection caused by Histoplasma capsulatum. Researchers tested four different diagnostic methods on serum samples from patients with histoplasmosis, varying in severity and immune status. They found that combining multiple testing methods provided the best results, with different techniques working better depending on whether patients had weakened immune systems from HIV or were otherwise healthy. The study also measured immune system chemicals called cytokines and found elevated levels in infected patients, suggesting these could help predict disease severity.

Read More »

Performance of the VITEK® MS system for the identification of filamentous fungi in a microbiological laboratory in Chile

Researchers tested a fast machine called VITEK® MS for identifying dangerous mold infections in patients. The machine correctly identified over 91% of fungal samples, which is much better than waiting weeks for traditional laboratory methods. This technology could help doctors start treatment much faster for patients with serious mold infections, potentially saving lives.

Read More »

Performance of the VITEK® MS system for the identification of filamentous fungi in a microbiological laboratory in Chile

This study tested a new laboratory technology called VITEK® MS for quickly identifying mold infections in patients. Researchers tested the system on 67 mold samples representing 35 different species. The technology successfully identified over 91% of the mold samples accurately without any misidentifications, making it a reliable tool for hospitals to quickly determine what type of mold is causing an infection so doctors can prescribe the right antifungal medication.

Read More »

Large language models and their performance for the diagnosis of histoplasmosis

Researchers tested whether artificial intelligence chatbots like ChatGPT and Microsoft Copilot could help doctors diagnose histoplasmosis, a serious fungal infection affecting people with HIV/AIDS that is often missed. They presented 20 real patient case descriptions to different AI systems and found that Microsoft Copilot performed best, correctly identifying histoplasmosis in 90% of cases—about as good as laboratory tests. While the AI showed promise as a helpful tool to suggest this neglected disease during diagnosis, doctors would still need to verify findings with actual tests.

Read More »

Polymerase Chain Reaction on Respiratory Tract Specimens of Immunocompromised Patients to Diagnose Pneumocystis Pneumonia: A Systematic Review and Meta-analysis

This study analyzed how well PCR tests detect Pneumocystis pneumonia, a serious fungal lung infection in immunocompromised patients. The research reviewed 55 studies with over 11,000 tests and found that PCR testing of fluid from the lungs or induced sputum works very well, especially at ruling out the disease when negative. However, positive test results need careful interpretation because the test can detect the fungus even when it’s just colonizing rather than causing active infection.

Read More »

Comparison of the Filamentous Fungi Library v4.0 MALDI Biotyper Platform vs MSI-2 performance for identifying filamentous fungi from liquid cultures

This study compared two advanced technologies for identifying dangerous fungi in clinical samples. The MALDI Biotyper FFLv4.0 system identified about 96% of fungi correctly when using liquid culture samples, outperforming the MSI-2 database which identified about 78.5%. Both systems had difficulty with certain difficult-to-distinguish species, especially within Aspergillus and Fusarium groups, but performed well with Mucorales fungi. The findings suggest that continuous updating of these fungal identification libraries is essential for improving patient care.

Read More »

Reevaluating the Value of (1,3)-β-D-Glucan for the Diagnosis of Intra-Abdominal Candidiasis in Critically Ill Patients: Current Evidence and Future Directions

This review examines how a fungal biomarker called beta-D-glucan (BDG) can help doctors diagnose yeast infections in the abdomens of critically ill patients. While BDG tests in the blood are available, they give many false positives. Testing BDG directly in fluid from the abdomen appears more accurate, especially when combined with blood tests. However, more research is needed before hospitals widely adopt this approach in daily practice.

Read More »
Scroll to Top